neffy®

The adrenaline device neffy®, a needle-free nasal spray, is planned to be launched in Australia in the first quarter of 2026. 

Allergy & Anaphylaxis Australia is actively working with CSL Seqirus to ensure we can share accurate, timely updates when the product is available on private prescription. We remain committed to providing the community with the most up-to-date information as soon as it becomes available.

Note: Now that neffy is registered with the Therapeutic Goods Administration (TGA) we await advice on availability as CSL Seqirus informs health professionals on availability and use.